Last Updated:
Name Designation Appointment Date Status
Yash Jayesh Joshi

Appointed as Director since February 2021

 Director 08-Feb-2021 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Indiaxis Pharmaceuticals Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.
Bhushan Jayesh Joshi

Appointed as Whole-time director since October 2021

 Whole-time director 09-Oct-2021 Current
Jayesh Jayantilal Joshi

Appointed as Director since May 2025

 Director 16-May-2025 Current

People Timeline

Explore the timeline of key personnel in Indiaxis Pharmaceuticals Private Limited's leadership journey.

Contact Details
  • Address 228, Ramgopal Industrial Estate, Dr. R.P. Road Mulund (W) , Mumbai -400080, Mumbai Maharashtra, 400080, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 400080
  • Country India
  • Website -
Frequently Asked Questions
You can contact Indiaxis Pharmaceuticals Private Limited through their registered address at 228, Ramgopal Industrial Estate, Dr. R.P. Road Mulund (W) , Mumbai -400080, Mumbai Maharashtra, 400080, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Indiaxis Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • BHUSHAN JAYESH JOSHI
  • JAYESH JAYANTILAL JOSHI
  • YASH JAYESH JOSHI
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available